Stay updated on YH001 Plus Envafolimab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the YH001 Plus Envafolimab in Sarcoma Clinical Trial page.

Latest updates to the YH001 Plus Envafolimab in Sarcoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new Revision: v3.4.2 was added to the history, and prior notices about funding lapse and Revision: v3.4.1 were removed, reflecting an administrative site update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check20 days agoChange DetectedA new site-wide funding notice was added and the page version updated to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check28 days agoChange DetectedGlossary toggle added; additions are shown in green and deletions in red to highlight changes in the Record History, with the latest revision labeled v3.4.0. A No FEAR Act Data note is now present and the earlier v3.3.4 reference has been removed.SummaryDifference1%

- Check42 days agoChange DetectedRevision: v3.3.4 was added. Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check64 days agoChange DetectedThe record history shows a new revision v3.3.3 added and the HHS Vulnerability Disclosure link removed (previous revision v3.3.2). These are administrative site-wide updates and do not alter study content or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedThe record history for NCT05448820 shows a new revision entry (v3.3.2) and removal of an earlier revision (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to YH001 Plus Envafolimab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the YH001 Plus Envafolimab in Sarcoma Clinical Trial page.